Michael Fu Head of Everbright Healthcare Fund and Managing Director China Everbright

Managing Director and Head of Everbright Healthcare Fund. Prior to Everbright, Mr. Fu worked as head of healthcare PE at Hillhouse, head of China healthcare at TPG Growth Capital, head of healthcare at FountainVest Partners and CITIC Pacific.

Mr. Fu has over 16 years’ experiences in investment, transactions range from early stage, growth to buyout. He has led and participated in investments in CP Guojian, CITIC Pharma, Lifetech, Fussen, Wuxi, Daopei, Amcare, Junshi and etc.

Prior to investment career, Mr. Fu had 8 years’ experience in operation with Sanjiu Pharmaceutical. He was the National Head of Sales and Marketing, responsible for both in-house products and exclusive agency business with multinational pharmaceutical companies.

Mr. Fu received MBA from University of British Columbia and Bachelor Degree of Economics and International Finance from East China Normal University. He is a CFA Charter holder as well.

Frank Liu Executive Director Citic Securities

刘晓岚先生2006年加入中信证券，拥有超过10年的医疗健康行业投行工作经验。曾作为项目负责人或现场负责人参与了以岭药业、中信国健、滇虹药业、益丰药房、沈阳三生、大理药业、赛诺医疗（科创板）等IPO项目、南京医药再融资、益丰药房可转债、哈药股份重大资产重组、益丰药房重大收购项目，并在灵康药业及甘李药业IPO等项目担任核心成员或技术支持工作。此外还参与了部分非医药类项目，包括中化国际分离交易可转债、中华企业再融资、南京新百重大资产重组、印度公司并购境内塑料制品企业等项目，拥有丰富的资本运作及项目经验。

刘晓岚先生毕业于加拿大McMaster大学，获工商管理硕士学位。

Josh Shin Partner Fangda Partners

Mr. Josh SHIN specializes in Mergers & Acquisitions, equity financing and advices on regulatory issues, with a strong track record in various industry sectors such as pharma, life science, healthcare, education and general industry. He currently acts as coordinator of Fangda’s healthcare practices, and has been named as leading individual in life sciences by Chambers Asia Pacific and Legal 500 for years.

Aaron Yu Co-General Manager, Investment Department Shanghai Fosun Pharmaceutical Group Co.,Ltd.

Speaker bio coming soon

JieLun Zhu Chief Financial Officer I-Mab

As the Chief Financial Officer, Jielun Zhu, MBA, CFA, is in charge of the overall financial strategy and management, capital investment, corporate finance and investor relations. He is a veteran and expert in the finance industry, with over 11 years of experience in investment banking. From December 2015 to July 2018, prior to joining I-Mab, he served as a managing director and Asia Head of Healthcare Investment Banking and Capital Markets in Hong Kong for Jefferies Group LLC, a global full-service investment bank with a strong focus in healthcare. At Jefferies, Mr. Zhu advised many biotechnology and healthcare clients globally on IPOs and other financings, as well as mergers and acquisitions. From August 2008 to September 2015, he worked for the Deutsche Bank Group in its Hong Kong office, occupying a succession of positions culminating in Director in the Corporate Finance Division, which entailed working with leading clients in the healthcare and other sectors in Greater China. From July 2007 to July 2008, he was an investment banker in Hong Kong with UBS AG. Before investment banking, Mr. Zhu was a strategy consultant in Boston focused on serving clients in the US pharmaceutical and biotechnology industry. Mr. Zhu earned his MBA from Harvard Business School with distinction in June 2007 and his Bachelor of Arts degree with honors in mathematics-economics from Wesleyan University. He is also a Chartered Financial Analyst (CFA) charterholder.

Toto Ku Head of Greater China Datasite

Toto Ku is the Head of Greater China at Datasite (formerly Merrill Corporation), responsible for the company’s rapid growth in the mainland. He leads the expansion of Datasite’s footprint in the market, now trusted by thousands of corporates and PEs in China to securely source, manage and execute their deals and transactions faster.

Toto has more than 10 years’ experience in the finance industry, holding senior management roles in portfolio companies of KKR, Bain Capital and other global organizations, with a focus on financial technologies.

He specializes in helping global companies establish their footprint in China, successfully developing multiple opportunities for business growth over the past decade. Toto also has set up several real estate brokerage firms in Hong Kong serving hedge funds and PEs.

Yiqing Wang China Editor/Head of APAC Editorial Operations Mergermarket

Yiqing Wang is China Editor/Head of APAC Editorial Operations for Mergermarket, a global news intelligence service for advisors, private equity firms and corporates. She leads a team of dedicated journalists across Greater China to cover PE/VC fundraising, M&A deals, PE buyouts and China cross-border M&A intelligence. 

Yiqing has been an investigative M&A reporter and researcher since 2009, writing industry news ranging from healthcare, new energy and financial service, etc. She achieved her master’s degree of multilingual multicultural studies from New York University.